Jasper Therapeutics Stock In The News

JSPR Stock  USD 5.49  0.11  2.04%   
Our overall analysis of Jasper Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Jasper Therapeutics. The specific impact of Jasper Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Jasper Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Jasper Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Jasper Therapeutics Backtesting and Jasper Therapeutics Hype Analysis.
To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.

Jasper Therapeutics Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Jasper Therapeutics Presents Clinical an...
https://www.globenewswire.com/news-release/2025/03/01/3035115/0/en/Jasper-Therapeutics-Presents-Clinical-and-Preclinical-Briquilimab-Data-at-the-American-Academy-of-Allergy-Asthma-and-Immunology-AAAAI-Annual-Meeting.html
 Neutral
Macroaxis News: globenewswire.com
Jasper Therapeutics Announces Late-Breaking Briquilimab Presentation at the American Academy of Dermatology (AAD) Annual Meeting
https://www.globenewswire.com/news-release/2025/02/28/3034708/0/en/Jasper-Therapeutics-Announces-Late-Breaking-Briquilimab-Presentation-at-the-American-Academy-of-Dermatology-AAD-Annual-Meeting.html
 Neutral
Macroaxis News: globenewswire.com
Jasper Therapeutics to Present at Upcoming March Investor Conferences
https://www.globenewswire.com/news-release/2025/02/25/3032474/0/en/Jasper-Therapeutics-to-Present-at-Upcoming-March-Investor-Conferences.html
 Neutral
Macroaxis News: globenewswire.com
Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
https://www.globenewswire.com/news-release/2025/02/10/3023402/0/en/Jasper-Therapeutics-Announces-Briquilimab-Presentations-at-the-American-Academy-of-Allergy-Asthma-and-Immunology-AAAAI-Annual-Meeting.html
 Neutral
Macroaxis News: globenewswire.com
Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference
https://www.globenewswire.com/news-release/2025/02/04/3020822/0/en/Jasper-Therapeutics-to-Present-at-the-Oppenheimer-Healthcare-Life-Sciences-Conference.html
 Neutral
Yahoo News
Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors
https://finance.yahoo.com/news/jasper-therapeutics-skin-disorder-candidate-152329616.html
 Neutral
Macroaxis News: globenewswire.com
Jasper Announces First Patient Dosed in Phase 1b/2a Clinical Study of Briquilimab in Chronic Spontaneous Urticaria
https://www.globenewswire.com/news-release/2023/11/30/2788522/0/en/Jasper-Announces-First-Patient-Dosed-in-Phase-1b-2a-Clinical-Study-of-Briquilimab-in-Chronic-Spontaneous-Urticaria.html
 Neutral
Macroaxis News: globenewswire.com
Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
https://www.globenewswire.com/news-release/2023/11/09/2777295/0/en/Jasper-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
 Neutral
Macroaxis News: globenewswire.com
Jasper Therapeutics to Participate at Upcoming Medical and Investor Conferences
https://www.globenewswire.com/news-release/2023/11/08/2776760/0/en/Jasper-Therapeutics-to-Participate-at-Upcoming-Medical-and-Investor-Conferences.html
 Neutral
Macroaxis News: globenewswire.com
Jasper Therapeutics Announces Oral Prese...
https://www.globenewswire.com/news-release/2023/11/02/2772363/0/en/Jasper-Therapeutics-Announces-Oral-Presentation-of-Positive-Final-Results-from-Phase-1-Study-of-Briquilimab-in-Patients-with-AML-or-MDS-Undergoing-Hematopoietic-Cell-Transplant-at-.html
 Neutral

Jasper Therapeutics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Jasper and other traded companies coverage with news coverage. We help investors stay connected with Jasper headlines for the 14th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Jasper Stock performance. Please note that trading solely based on the Jasper Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Jasper Therapeutics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Jasper Therapeutics investors visualize upcoming and past events in order to time the market based on Jasper Therapeutics noise-free hype analysis.
Jasper Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Jasper earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Jasper Therapeutics that are available to investors today. That information is available publicly through Jasper media outlets and privately through word of mouth or via Jasper internal channels. However, regardless of the origin, that massive amount of Jasper data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Jasper Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Jasper Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Jasper Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Jasper Therapeutics alpha.

Jasper Largest EPS Surprises

Earnings surprises can significantly impact Jasper Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-09
2024-06-30-1.09-0.970.1211 
2024-11-07
2024-09-30-1.07-1.24-0.1715 
2024-05-14
2024-03-31-1.23-1.030.216 
2022-05-12
2022-03-31-0.35-0.060.2982 
2025-03-03
2024-12-31-1.2278-1.62-0.392231 
2021-11-12
2021-09-30-0.28-0.69-0.41146 
View All Earnings Estimates

Jasper Therapeutics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Jasper Therapeutics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
6th of March 2025
FY2025 EPS Estimates for JSPR Raised by Cantor Fitzgerald - Defense World
at news.google.com 
Gurufocus Stories at Macroaxis
28th of February 2025
Jasper Therapeutics Announces Late-Breaking Briquilimab Presentation at the American Acade...
at gurufocus.com 
Gurufocus Stories at Macroaxis
25th of February 2025
Jasper Therapeutics to Present at Upcoming March Investor Conferences
at gurufocus.com 
Yahoo News
10th of February 2025
Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy...
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
4th of February 2025
Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference
at gurufocus.com 
news
22nd of January 2025
Analysts Offer Predictions for JSPR FY2025 Earnings
at thelincolnianonline.com 
benzinga news
8th of January 2025
US Stocks Down Acuity Brands Posts Weak Revenue
at benzinga.com 

Jasper Therapeutics Investors Sentiment

The influence of Jasper Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Jasper. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Jasper Therapeutics' public news can be used to forecast risks associated with an investment in Jasper. The trend in average sentiment can be used to explain how an investor holding Jasper can time the market purely based on public headlines and social activities around Jasper Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Jasper Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Jasper Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Jasper Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Jasper Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Jasper Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Jasper Therapeutics' short interest history, or implied volatility extrapolated from Jasper Therapeutics options trading.

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.